HIV incidence among women of reproductive age in Malawi and Zimbabwe.
Newton Kumwenda, Irving Hoffman, Mike Chirenje...
https://pubmed.ncbi.nlm.nih.gov/16773032Completed
Led by National Institute of Allergy and Infectious Diseases (NIAID) · Updated on 2021-10-29
4400
Participants Needed
1
Research Sites
N/A
Total Duration
The purpose of this study is to see if nonoxynol-9 (N-9) gel used in the vagina can prevent the spread of HIV. Most of the people with HIV in the world today live in southern Africa. Because this population is not likely to use condoms, an HIV-prevention method that women can control is needed. N-9 used in the vagina may help prevent the spread of HIV and other sexually transmitted diseases.
CONDITIONS
A Study of Nonoxynol-9 (N-9) and HIV Infection
You may qualify if you...
Inclusion Criteria
Volunteers may be eligible if they:
Exclusion Criteria
Volunteers will not be eligible if they:
You will not qualify if you...
History of severe allergic reactions to study medication Currently pregnant or breastfeeding Recent participation in another clinical trial within the last 30 days Presence of uncontrolled medical conditions that could affect safety
Total: 1 location
1
Julia Welch
Research Triangle Park, North Carolina, United States, 27709
Status Unknown
Study Type
INTERVENTIONAL
Masking
DOUBLE
Allocation
N/A
Model
N/A
Primary Purpose
PREVENTION
Number of Arms
0
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Newton Kumwenda, Irving Hoffman, Mike Chirenje...
https://pubmed.ncbi.nlm.nih.gov/16773032